FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Holliday Keith
2. Issuer Name and Ticker or Trading Symbol

STAAR SURGICAL CO [ STAA ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chief Technology Officer
(Last)          (First)          (Middle)

25651 ATLANTIC OCEAN DRIVE
3. Date of Earliest Transaction (MM/DD/YYYY)

11/4/2019
(Street)

LAKE FOREST, CA 92630
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  11/4/2019    S    2100  D $35.00  28764  D   
Common Stock  11/5/2019    S    14441  D $35.00  14323  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:

Remarks:
Transactions executed pursuant to Dr. Holliday's pre-existing Rule 10b5-1 plan.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Holliday Keith
25651 ATLANTIC OCEAN DRIVE
LAKE FOREST, CA 92630


Chief Technology Officer

Signatures
/s/ Samuel Gesten as attorney-in-fact for Keith Holliday. 11/6/2019
**Signature of Reporting Person Date


STAAR Surgical (NASDAQ:STAA)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more STAAR Surgical Charts.
STAAR Surgical (NASDAQ:STAA)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more STAAR Surgical Charts.

Staar Surgical Co News

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel
Wednesday 1 May 2024 (4 days ago) • Business Wire
STAAR Surgical to Report First Quarter Results on May 7, 2024
Monday 29 April 2024 (6 days ago) • Business Wire
STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024
Thursday 4 April 2024 (1 month ago) • Business Wire
STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024
Tuesday 2 April 2024 (1 month ago) • Business Wire
STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses
Monday 18 March 2024 (2 months ago) • Business Wire
STAAR Surgical Adds Arthur Butcher and Wei Jiang to Board of Directors
Tuesday 12 March 2024 (2 months ago) • Business Wire
Form 4 - Statement of changes in beneficial ownership of securities
Monday 11 March 2024 (2 months ago) • Edgar (US Regulatory)
STAAR Surgical to Participate in Two Upcoming Investor Conferences
Wednesday 6 March 2024 (2 months ago) • Business Wire
Expedia Announces 1,500 Job Cuts; Hims & Hers Surges 19.8% Post Financial Results, and More News
Tuesday 27 February 2024 (2 months ago) • IH Market News
STAAR Surgical Reports Fourth Quarter and Fiscal Year 2023 Results
Tuesday 27 February 2024 (2 months ago) • Business Wire
STAAR Surgical to Report Fourth Quarter Results on February 26, 2024
Monday 19 February 2024 (3 months ago) • Business Wire
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Saturday 27 January 2024 (3 months ago) • Edgar (US Regulatory)